Clinical trial
Depsipeptide to Treat Thyroid and Other Advanced Cancers
NCT00048334 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00048334 |
|---|---|
| Title | Depsipeptide to Treat Thyroid and Other Advanced Cancers |
| Official title | Phase I Trial of Romidepsin Given on Days One, Three, and Five in Patients With Thyroid and Other Advanced Cancers |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | Depsipeptide, FR901228, FK228 |
| Enrollment | 28 |
| Start date | Oct 26, 2002 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Oct 30, 2002 |
| Last update posted | Dec 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: